Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Share your requirement and our team will take it forward with
clarity, confidentiality, and technical precision.
Related Products
N-Nitroso Moxifloxacin EP Impurity A
| CAT No | SRC-N014855 |
| CAS No | NA |
| Mol.F. | C20H20F2N4O4 |
| Mol.Wt. | 418.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Moxifloxacin EP Impurity B
| CAT No | SRC-N014856 |
| CAS No | NA |
| Mol.F. | C22H26N4O6 |
| Mol.Wt. | 442.5 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Moxifloxacin EP Impurity C
| CAT No | SRC-N014857 |
| CAS No | NA |
| Mol.F. | C22H25FN4O5 |
| Mol.Wt. | 444.5 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Moxifloxacin EP Impurity D
| CAT No | SRC-N014858 |
| CAS No | NA |
| Mol.F. | C21H23FN4O5 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Moxifloxacin EP Impurity G
| CAT No | SRC-N014859 |
| CAS No | NA |
| Mol.F. | C21H23FN4O5 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Moxifloxacin Decarboxy Analog
| CAT No | SRC-N014860 |
| CAS No | NA |
| Mol.F. | C20H23FN4O3 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
Betahistine Nitroso Methylamine Impurity
| CAT No | SRC-N014861 |
| CAS No | NA |
| Mol.F. | C9H13N3O |
| Mol.Wt. | 179.2 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Betahistine EP Impurity C
| CAT No | SRC-N014862 |
| CAS No | NA |
| Mol.F. | C14H16N4O |
| Mol.Wt. | 256.3 g/mol |
| INV STATUS | In Stock |
N-Nitroso Paracetamol
| CAT No | SRC-N014863 |
| CAS No | 146897-60-1 |
| Mol.F. | C8H8N2O3 |
| Mol.Wt. | 180.2 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Paracetamol EP Impurity D
| CAT No | SRC-N014864 |
| CAS No | 938-81-8 |
| Mol.F. | C8H8N2O2 |
| Mol.Wt. | 164.2 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Paracetamol EP Impurity M
| CAT No | SRC-N014865 |
| CAS No | NA |
| Mol.F. | C12H10N2O3 |
| Mol.Wt. | 230.2 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Metformin
| CAT No | SRC-N014866 |
| CAS No | NA |
| Mol.F. | C4H10N6O |
| Mol.Wt. | 158.2 |
| INV STATUS | In Stock |
N-Nitroso Metformin EP Impurity A
| CAT No | SRC-N014867 |
| CAS No | NA |
| Mol.F. | C2H3N5O |
| Mol.Wt. | 113.1 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Metformin Impurity 1
| CAT No | SRC-N014868 |
| CAS No | NA |
| Mol.F. | C3H8N6O |
| Mol.Wt. | 144.1 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Metformin Impurity 2
| CAT No | SRC-N014869 |
| CAS No | NA |
| Mol.F. | C3H8N6O |
| Mol.Wt. | 144.1 |
| INV STATUS | CUSTOM SYNTHESIS |
Ivacaftor Nitroso Impurity 1
| CAT No | SRC-N014870 |
| CAS No | NA |
| Mol.F. | C10H6N2O4 |
| Mol.Wt. | 218.2 |
| INV STATUS | CUSTOM SYNTHESIS |